TargetRx Expands Management Team to Support Continued Growth

Industry Leaders from IMS & Verispan Join TargetRx to Field Increasing Demand for Pharma & Biotech Sales & Marketing Solutions

Horsham, Pa. - September 14, 2009 - With a 25 percent increase in year over year revenue and a growing portfolio of pharmaceutical and biotech clients, TargetRx today announced the addition of Dave Dornstreich as vice president of business development and David Deutsch as vice president of client service and development. Each executive will play a key role in supporting the expansion of TargetRx's customer base and leading the development of new pharmaceutical sales and marketing effectiveness solutions.

"With the challenging economic environment and the industry's focus on building a new commercial model, pharmas and biotechs are looking to reevaluate and justify every sales and marketing spend - making our solutions more critical than ever," said Craig Scott, CEO of TargetRx. "As a result, we've added key industry players to our management team to not only support new and expanding client relationships, but also drive our continued investment in our service offerings."

TargetRx's new Vice President of Business Development Dave Dornstreich brings more than 20 years pharmaceutical and healthcare industry experience in sales, sales management, marketing and product development. Most recently, Dave served as vice president of sales for i3 Pharma Informatics, an Ingenix company, where he led the start up of the organization. Prior to i3, he was chief revenue officer for Mirixa Corporation. Before joining Mirixa, Dave spent eight years as vice president of sales for Verispan, where he played a leadership role in the firm's longitudinal patient data business. Dave has also held several positions with Quintiles in business development and a number of sales and sales operations roles with Ciba-Geigy, IMS, Knoll Pharmaceutical and Colgate Palmolive. Dave has a BA in political science from Hofstra University.

David Deutsch brings a wealth of global experience in every channel of the health care marketplace to his new role as vice president of client service and development. Most recently, David served as senior principal and oncology thought leader at IMS Health. With an MPH in health services management from Johns Hopkins University, David has held health care planning and delivery roles within the Maryland State Department of Health, the Johns Hopkins Hospital Health System, the U.S. Department of Health & Human Services and the National Health Service in the United Kingdom. He also held international marketing, market research and policy positions with Baxter International, G.D. Searle and Bristol Myers Squibb before founding Biotext, a strategic market research and medical communications agency, which he built and eventually merged into Quintiles Transnational. David subsequently served in senior management positions with Quintiles, Datamonitor, P\S\L Research International and the MattsonJack Group.

"TargetRx's strong performance over the past 18 months has put us in the fortunate position to add recognized talents like Dave Dornstreich and David Deutsch to our management team," said Scott. "With a deep understanding of the intricacies of this space, both have proven that they have what it takes to help clients compete and succeed in this rapidly evolving biopharmaceutical marketplace."

For more information on TargetRx's management team, please visit http://www.targetrx.com/trx/corporate/management/.

About TargetRx

TargetRx provides pharmaceutical and biotech companies with unique insight into the true drivers of product choice and adoption for their brands, helping clients to confidently take the actions that will grow their businesses and help patients. Serving the majority of the top 30 pharmaceutical and biotech companies, TargetRx enables clients to significantly improve the launch of new products and indications, physician segmentation and targeting, creation of professional messaging and materials, and sales and marketing execution and effectiveness. All TargetRx solutions are powered by our AdvantageBuilderSM normative database and validated predictive models, created from capturing in-depth physician attitudes on the "four forces" of prescribing - product, payor, promotion and patient - on new launches, marketing campaigns and physician-rep interactions on over 500 pipeline and inline brands and modeling these attitudes against actual prescribing behavior. For more information, visit www.targetrx.com.

Media Contact:

Patrick Howie
Phone: 215.444.8746
phowie@targetrx.com